Assessment of Early Phase $^{18}{\rm F}$-FP-CIT PET as an Alternative Method of FDG PET for Voxel Based Statistical Analysis: Application for Parkinson's Disease Rat Model
暂无分享,去创建一个
Hee-Joung Kim | Kyeong Min Kim | Sang Moo Lim | Joo Hyun Kang | Jin Su Kim | A. Ram Yu | Jisook Moon | Yun Young Choi | Kyeong-Min Kim | J. Kang | Jisook Moon | Hee-Joung Kim | Sang-Moo Lim | Y. Choi | Jin Su Kim | A. Yu
[1] Dae Hyuk Moon,et al. Assessment of Cerebral Glucose Metabolism in Cat Deafness Model: Strategies for Improving the Voxel-Based Statistical Analysis for Animal PET Studies , 2008, Molecular Imaging and Biology.
[2] Johan Nuyts,et al. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] P. Seeman,et al. The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus , 1991, Journal of neurochemistry.
[4] Yann Cointepas,et al. Validation of a Standardized Normalization Template for Statistical Parametric Mapping Analysis of 123I-FP-CIT Images , 2007, Journal of Nuclear Medicine.
[5] V. Dhawan,et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] Val J Lowe,et al. NEMA NU 2-2007 performance measurements of the Siemens Inveon™ preclinical small animal PET system , 2009, Physics in medicine and biology.
[7] V. Dhawan,et al. Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study , 2002, Synapse.
[8] Karl J. Friston,et al. Spatial registration and normalization of images , 1995 .
[9] S J Kish,et al. [11C]RTI‐32 PET studies of the dopamine transporter in early dopa‐naive Parkinson's disease , 1997, Neurology.
[10] V. Dhawan,et al. Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] Paul Kinahan,et al. Analytic 3D image reconstruction using all detected events , 1989 .
[12] Yu-Ping Jiang,et al. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson’s disease in various Hoehn & Yahr stages , 2007, Journal of Neurology.
[13] Ren-Shyan Liu,et al. Crossover Study of 99mTc-TRODAT-1 SPECT and 18F-FDOPA PET in Parkinson’s Disease Patients , 2003 .
[14] Qinan Bao,et al. Performance Evaluation of the Inveon Dedicated PET Preclinical Tomograph Based on the NEMA NU-4 Standards , 2009, Journal of Nuclear Medicine.
[15] M Laruelle,et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] A. Formiconi,et al. Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson’s disease , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[17] T. Ishikawa,et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] M. Kaufman,et al. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's‐diseased striatum , 1991, Synapse.
[19] J. Ashburner,et al. Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.